Document detail
ID

oai:arXiv.org:2408.01230

Topic
Computer Science - Robotics Computer Science - Machine Learnin...
Author
Hao, YiFan Yang, Yang Song, Junru Peng, Wei Zhou, Weien Jiang, Tingsong Yao, Wen
Category

Computer Science

Year

2024

listing date

8/7/2024

Keywords
based graph morphologies heteromorpheus control
Metrics

Abstract

In the field of robotic control, designing individual controllers for each robot leads to high computational costs.

Universal control policies, applicable across diverse robot morphologies, promise to mitigate this challenge.

Predominantly, models based on Graph Neural Networks (GNN) and Transformers are employed, owing to their effectiveness in capturing relational dynamics across a robot's limbs.

However, these models typically employ homogeneous graph structures that overlook the functional diversity of different limbs.

To bridge this gap, we introduce HeteroMorpheus, a novel method based on heterogeneous graph Transformer.

This method uniquely addresses limb heterogeneity, fostering better representation of robot dynamics of various morphologies.

Through extensive experiments we demonstrate the superiority of HeteroMorpheus against state-of-the-art methods in the capability of policy generalization, including zero-shot generalization and sample-efficient transfer to unfamiliar robot morphologies.

Hao, YiFan,Yang, Yang,Song, Junru,Peng, Wei,Zhou, Weien,Jiang, Tingsong,Yao, Wen, 2024, HeteroMorpheus: Universal Control Based on Morphological Heterogeneity Modeling

Document

Open

Share

Source

Articles recommended by ES/IODE AI

MELAS: Phenotype Classification into Classic-versus-Atypical Presentations
presentations mitochondrial strokelike patients variability phenotype clinical melas
Protocol for the promoting resilience in stress management (PRISM) intervention: a multi-site randomized controlled trial for adolescents and young adults with advanced cancer
cancer quality of life anxiety depression hope coping skills communication intervention randomized ayas outcomes resilience care trial cancer prism-ac advanced